In 2016, the global market for nanoparticles-metal & metal oxides in healthcare was valued at USD 25.86 million. One of the main factors for the estimated revenue is the presence of a significant number of metal nanoparticle based drugs that have been approved by the U.S. FDA. There are also a lot of products that are in the clinical and investigational stages of development, which will increase the industrial appeal of this field.
These particles are versatile and can be used in many biomedical applications, including radiotherapy enhancement, thermal ablation, radiotherapy enhancement, high sensitive diagnostic assays and drug & Gene delivery. In the future, technological advancements that reduce adverse events related to the use of these products will influence the pace of progress.
U.S. market for nanoparticles & metal oxides in healthcare, according to application, 2013-2025 (USD billion)
Scientists and biologists are currently conducting research to improve our understanding of metallic nanoparticles to decrease the toxic effects. These developments will likely lead to an increase in the production and sales of these molecules over the forecast period.
The pharmaceutical industry is a dynamic marketplace that changes with rising manufacturing costs, evolving regulatory standards and a growing need for effective, sophisticated health solutions. These factors are continually putting pressure on pharmaceutical producers to fulfill the untapped market demand. Because of these factors, nanoparticle technology is a source of high-quality revenue generation. They have significant potential to aid in disease management.
Market growth will be driven by the presence of many projects in R&D. This will increase the market's future product offerings. The high potential for revenue in this market is further bolstered by the existence of government-backed programs like the National Nanotechnology Initiative (NNI), which was launched in 2000 and provides support for advance R&D projects related to nanomedicine development.
Due to their widespread adoption in therapeutic development, gold nanoparticles accounted for the largest percentage. This steady increase in gold nanoparticle adoption is due to factors such as greater compatibility, low toxicity & tunable stability, small dimensions, and better compatibility.
Moreover, gold nanocages coated with the temperature-sensitive polymer are applicable in targeted drug delivery that on interaction with near-infrared radiations, release effectors. These effectors can be used to monitor drug interactions and provide efficient control. This is why they are becoming increasingly popular in imaging, disease monitoring and drug delivery applications.
Alumina-based molecules will continue to grow because of the growing interest in its therapeutic uses for targeted cell destruction. Because of its high porosity, aluminum oxide is being used in combination with polymeric membranes to enhance drug delivery.
In-vivo imaging accounts for the largest revenue share. This is due to increasing use of nanoshells like Au3Cu1 which are reported to increase contrast for blood vessels in order to be used for in vivo MR angiography. AuNPs can also be used as probes to enable both in-vivo and in-vitro visual monitoring for protease activity.
Targeted delivery will show the highest YoY growth due to ongoing research into drug delivery applications using nanotechnology. The development of photo-modulated nanoshells to deliver drugs is expected to increase the technology's adoption.
Market for nanoparticles in the metal & oxides market in healthcare by region, 2016, (%)
North America was the country with the highest revenue share in 2016, thanks to the existence of strong regulatory guidelines for therapeutic development in the region. The region is seeing inter-country cooperation in the production and use of nanoparticles. The Regulatory Cooperation Council (RCC) was one example of how the U.S., Canada and other countries collaborated in nanomaterials research. In January 2014, Washington DC hosted a conference to finalize the regional nanotechnology work plan.
Asia Pacific will see the most rapid growth due to increased investment in nanoparticle production and increase in clinical studies to determine the toxicity of nanoparticles. The potential nanotechnology hubs in the near future have been identified as Asian countries. This has led to an increase in research on nanomolecules.
Pfizer Inc., Nanobiotix, nanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham, and Women's Hospital(BWH) are some of the major players in this market. The pharma-biotech market requires large capital investments and is highly research-intensive in nature. For their detection and characterisation, market entities work to develop more advanced analysis tools.
The global market for nanoparticles is expected to be driven by product innovations in human therapeutics, and growing global demand for strong disease treatment solutions. The presence of many products in development and a large number opportunistic clinical trials will further boost revenue. Nano biotechnology has attracted large amounts of R&D investment for nanoparticle-based drugs & chemotherapeutic agents.
This report provides a forecast of revenue growth at the country and regional level, and an analysis on the most recent trends and opportunities in each sub-segment from 2013 through 2025. Up Market Research has divided the Nanoparticles-metal & Metal Oxides market in Healthcare on the basis type, application, region, and purpose.
Type Outlook (Revenue, USD Billion; 2013 - 2025)
Nanoparticles of Gold
Silver Nanoparticles
Iron Oxide Nanoparticles
Alumina Nanoparticles
Gadolinium Oxide Nanoparticles
Other
Application Outlook (Revenue, USD Billion; 2013 - 2025)
In-vivo Imaging
Targeted drug delivery
Proton Therapy
In-vitro Assays
Cell & Phantom Imaging
Regional Outlook (Revenue USD Billion; 2013-2025)
North America
The U.S.
Canada
Europe
Germany
UK
Asia Pacific
Japan
China
Latin America
Brazil
Middle East and Africa (MEA).
South Africa
b. Global market for nanoparticles metals and metal oxides was valued at USD 36.07 Billion in 2019, and is forecast to grow to USD 40.73 Billion by 2020.
What is the market growth for nanoparticles metals and metal oxides?b. Global nanoparticles metals and metal oxides markets are expected to grow at a compound annual rate of 13.78% between 2018-2025, to reach USD 80.74 trillion by 2025.
Which market segment had the largest share of nanoparticles metal or metal oxides?b. With a 41.5% share in 2019, North America was the dominant market for nanoparticles metals and metal oxides. This can be attributed to the existence of effective regulatory guidelines in North America regarding therapeutic development and collaboration between countries for the production nanoparticles.
What are the major players in the market for nanoparticles metal or metal oxides?b. Pfizer Inc., Nanobiotix, nanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham and Women's Hospital, (BWH) are some of the key players in the telemedicine marketplace.
What are the main factors that drive the market for nanoparticles metal or metal oxides?b. The market growth is driven by the presence of many metal nanoparticle-based medicines, their versatility, and technological advances.
Up Market Research published a new report titled “Nanoparticles - Metal & Metal Oxides Market research report which is segmented by Type (Alumina, Iron Oxide, Gold, Silver, Cerium, Gadolinium), by Application (In-vitro assays, Targeted Drug Delivery, In-vivo Imaging, Proton Therapy), By Players/Companies Nanobiotix, nanoComposix, Inc, Merck KGaA, Nanospectra Biosciences, Brigham, Immunolight LLC, AstraZeneca, Women's Hospital (BWH) Pharma-biotech market involves huge capital investment and is research intensive in nature Market entities are engaged in the development of more sophisticated analysis tools for their detection and characterization, Pfizer Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Nanoparticles - Metal & Metal Oxides Market Research Report |
By Type | Alumina, Iron Oxide, Gold, Silver, Cerium, Gadolinium |
By Application | In-vitro assays, Targeted Drug Delivery, In-vivo Imaging, Proton Therapy |
By Companies | Nanobiotix, nanoComposix, Inc, Merck KGaA, Nanospectra Biosciences, Brigham, Immunolight LLC, AstraZeneca, Women's Hospital (BWH) Pharma-biotech market involves huge capital investment and is research intensive in nature Market entities are engaged in the development of more sophisticated analysis tools for their detection and characterization, Pfizer Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 220 |
Number of Tables & Figures | 154 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type (Alumina, Iron Oxide, Gold, Silver, Cerium, Gadolinium), by Application (In-vitro assays, Targeted Drug Delivery, In-vivo Imaging, Proton Therapy).
Nanoparticles - Metal & Metal Oxides Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Nanoparticles - Metal & Metal Oxides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Nanoparticles - Metal & Metal Oxides Market Report:
Some other reports from this category!